Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Inventory (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Inventory for 4 consecutive years, with $53548.0 as the latest value for Q4 2025.

  • Quarterly Inventory rose 93.96% to $53548.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53548.0 through Dec 2025, up 93.96% year-over-year, with the annual reading at $53548.0 for FY2025, 93.96% up from the prior year.
  • Inventory for Q4 2025 was $53548.0 at bioAffinity Technologies, up from $35234.0 in the prior quarter.
  • The five-year high for Inventory was $53548.0 in Q4 2025, with the low at $5540.0 in Q4 2022.
  • Average Inventory over 4 years is $23203.1, with a median of $21923.5 recorded in 2023.
  • The sharpest move saw Inventory fell 16.3% in 2024, then skyrocketed 308.79% in 2025.
  • Over 4 years, Inventory stood at $5540.0 in 2022, then skyrocketed by 233.65% to $18484.0 in 2023, then surged by 49.36% to $27608.0 in 2024, then surged by 93.96% to $53548.0 in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $53548.0, $35234.0, and $43971.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.